Maha Hussein

19PUBLICATIONS
155CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsApplied geophysicsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 27, 2026
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.

Andrew J Armstrong, Arun A Azad, Taro Iguchi

|Feb 26, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Dec 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.

Soumyajit Roy, Yilun Sun, Maha Hussain

|Jun 18, 2025
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?

Cora N Sternberg, Maha Hussain

|Dec 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.

Neal Shore, Sarah M Nielsen, Edward D Esplin

|Aug 08, 2024
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).

Maha Hussain, Masha Kocherginsky, Neeraj Agarwal

Pageof 4

Frequent Collaborators

7 joint publications

Fred Saad

6 joint publications

Neeraj Agarwal

5 joint publications

Michael J Morris

4 joint publications

Karim Fizazi